Lingshi Tan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
dMed-Clinipace Closes US$50M Series C+ Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Recently merged CRO Clinipace raises $50M in new funding
wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.
Virgo Investment Group LLC ("Virgo") announced portfolio company Clinipace Incorporated ("Clinipace"), a full-service Clinical Research Organization ("CRO") headquartered in Raleigh, North Carolina, has merged with dMed Global ("dMed"), a full-service CRO based in Shanghai, China. The strategic merger will create a global mid-size CRO that will deliver innovative solutions to patients worldwide, and meet the needs of fast-moving biotech, pharma, and medical device companies around the world. Together, Clinipace and dMed will offer advanced technologies, expertise in multiple therapeutic areas, and a footprint that will drive continued excellence for their collective customers.
Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics
News provided by
Share this article
Share this article
HANGZHOU, China and SHANGHAI, March 2, 2021 /PRNewswire/ Innoforce, a biopharmaceutical innovation enabling platform and PDMO (Partner Development and Manufacturing Organization), and dMed, a clinical CRO with strong presence in China and the US - the world s two largest pharmaceutical and drug development markets, have signed an agreement under which the two parties agreed to establish a partnership to identify, assess, and collaborate on the development of clinical-stage therapeutics.
Dr. Lingshi Tan, founder and CEO of dMed said, Our partnership with Innoforce will provide a powerful avenue to help clinical-stage therapeutic development programs from small and medium companies and to accelerate the pace of clinical development.